/Companies

ActX

Seattle, US · Founded 2012 · Delaware corporation · 2 known investors

Find your way into ActX

Sign up to see every warm intro you have to ActX

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ActX team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ActX provides Actionable Genomics, an evidence-based genetic analysis service covering medication use and hereditary disease risk, aimed at making precision medicine a standard of care. It serves patients, physicians, and health systems by integrating genetic risk information into clinical care.

Founders & leadership

ActX was founded in 2012 by Stephen Scheer and Andrew Ury.

SSStephen Scheer
Stephen ScheerFounderStephen Scheer previously held a Vice President of Business Development role in biotechnology and electronic health record companies, with expertise in sales management, product management, and healthcare operations. He is the founder of ActX.
AU
Andrew UryFounderA physician and health IT executive, he led Physician Micro Systems from 1983 to 2007 and its successor Practice Partner as CEO, then served as Chief Medical Officer at McKesson Provider Technologies. He has also been a commissioner of the Certification Commission for Health Information Technology, vice chair of the EHR Association, and chairman of Aucolla.

Board

DB
Doug BevisBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$10.2M disclosed across 4 rounds · 2014–2022

▶$6MraisedDec 2022 · 43 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric MichelmanDirector
  • Sarah CorleyDirector
  • Andrew UryExecutive Officer, Director
Offering amount
$6.1M
Amount sold
$6M
Minimum investment
$10K
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedJul 2017 · 37 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John O?HalloranDirector
  • Andrew UryExecutive Officer, Director
  • Sarah CorleyDirector
Offering amount
$3.1M
Amount sold
$3.1M
First sale
Oct 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$308.8KraisedMar 2016 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew UryExecutive Officer, Director
  • Doug BevisDirector
Offering amount
$500K
Amount sold
$308.8K
Minimum investment
$5.8K
First sale
Mar 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedJul 2014 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew UryExecutive Officer, Director
  • Doug BevisDirector
Offering amount
$750K
Amount sold
$750K
Minimum investment
$9.7K
First sale
Jul 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as ActX.

Frequently asked questions

What does ActX do?
ActX provides Actionable Genomics, an evidence-based genetic analysis service covering medication use and hereditary disease risk, aimed at making precision medicine a standard of care. It serves patients, physicians, and health systems by integrating genetic risk information into clinical care.
Who founded ActX?
ActX was founded by Stephen Scheer, Andrew Ury in 2012.
Who are ActX's investors?
ActX's investors include Arieal Southeast Angel Partners, Keiretsu Forum.
How much funding has ActX raised?
ActX has disclosed $10.2M raised across 4 rounds.
Where is ActX headquartered?
ActX is headquartered in Seattle, US.